Periodic Reporting for period 1 - SmartSyringe (SmartSyringe, world easiest, safest and fastest blood collection ever made.)
Reporting period: 2018-05-01 to 2018-09-30
We are developing a needle-free solution which is able to extract and collect capillary blood in a simple, safe and painless way: SmartSyringe. It is a revolutionary technology which enables simple, safe and painless blood collection without needles. It enjoys several advantages over venous blood sampling: it is less invasive, it requires smaller amounts of blood volume and it can be performed quickly and easily.
The ultimate objective is to make SmartSyringe ready for market launch in Europe. This entails a number of technical and strategic objectives, including the completion of product development, the industrialization to reach commercial scale production, the clinical validation through a European clinical study and the exploitation of its results. The SME-I plays a key role in this strategy by providing the financial resources needed for a rapid and effective market uptake.
Annual blood testing is the most important step aging adults can take to prevent life-threatening disease. With the share of elderly people rapidly increasing, capillary blood testing is particularly recommended for old age patients, due to the damage or weakening of blood vessels. Having the proper blood tests can empower society to enact a science-based disease-prevention program that could add decades of healthy life. In these settings, SmartSyringe can offer a more efficient blood collection method and a greatly improved patient experience.